Valuation (67%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 9.52 | N/A |
PEG Ratio (TTM) | 0.25 | N/A |
P/S Ratio (TTM) | 30.75 | N/A |
P/B Ratio (TTM) | 1.04 | N/A |
P/FCF Ratio (TTM) | 0.76 | N/A |
Price to 5YR AVG Earnings Ratio | -12.75 | N/A |
Price to 5YR AVG FCF Ratio | 17.45 | N/A |
Profitability (55%) |
Company | Industry |
---|---|---|
ROA (TTM) | 7.04% | N/A |
ROE (TTM) | 10.97% | N/A |
Net Profit Margin (TTM) | 330.24% | N/A |
ROIC 5YR AVG | -3.29% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -110.15% | -164.76% | -93.81% |
Revenue | -9.05% | -169.99% | -96.08% |
Net Income | -111.09% | -172.96% | -98.09% |
Cash Flow | 5.62% | 437.40% | 242.44% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.53 | N/A |
Quick Ratio (TTM) | 1.53 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 3.91 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | -0.67% | N/A |